Lupin Ltd. and Lupin Pharmaceuticals continue to challenge Genzyme Corporation’s U.S. Patent No. 5,667,775, which expires in 2014.
The Company received notice in 2009 from Lupin that it had submitted to…
Genzyme Corporation is pursuing lawsuits against Lupin Ltd. and Lupin Pharmaceuticals and Impax Laboratories, Inc., alleging infringement of Renagel and Renvela patents.
Beginning in January 2009, the company received notices from…
Abbott Laboratories is seeking to enforce its patent rights relating to niacin extended release tablets, according to the Company’s latest Quarterly Report filed with the U.S. Securities and Exchange Commission…